The global demand for Contrast-Enhanced Digital Mammography Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Contrast-enhanced mammography is an emerging modality with many current and developing clinical applications, such as depicting abnormalities seen at screening, demonstrating disease extent, depicting response to neoadjuvant therapy, and breast cancer screening. CEDM generates a high-resolution, low-energy, full-field digital mammography image and, similar to MRI, a contrast-enhanced image that provides lesion vascularity information. The resulting contrast enhanced subtraction images maximize the conspicuity of iodinated contrast agent in the breast while minimizing the structured noise of non-enhancing fibroglandular tissue, thus revealing lesions with higher neovascularity and extracellular leakage of contrast agent more apparently. The high spatial resolution of the digital detector reveals lesion details with approximately ten times the spatial resolution of breast MRI.
Breast cancer is the most frequent cancer among women, impacting 2.1 million women each year, and also causes the greatest number of cancer-related deaths among women. In 2018, it is estimated that 627,000 women died from breast cancer. Rising case of breast tumor and cost effective of the contrast-enhanced digital mammography modality are the factors projected to propel the contrast-enhanced digital mammography market during the forecast period. However, lack of awareness about the technology among the people in developing countries is expected to hamper the market during the forecast period.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of contrast-enhanced digital mammography.
The entire contrast-enhanced digital mammography market has been sub-categorized into image type and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Image Type
- Diagnostic Laboratories
This section covers regional segmentation which accentuates on current and future demand for contrast-enhanced digital mammography market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Contrast Enhanced Digital Mammography Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the contrast-enhanced digital mammography market include Hologic, Inc., GE Healthcare, Planmed OY, and Allengers. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.